- 20% lower costs per SEK sold from Q2 2023
- Managed RPM in the US drives growth
Coala Life announces that the company confirms its communicated financial goals, to reach positive cash flow and positive EBITDA no later than 2024. Furthermore, it is estimated that the company’s costs per SEK sold, i.e. in relation to turnover, will decrease by 20% from Q2 2023. The business within Managed RPM in the US is the engine for Coala Life’s growth and guarantees that the financial goals will be reached.
The growth in the company’s business within Managed RPM in USA continues to deliver. Coala Life will also be able to reduce costs at the beginning of 2023. During the first half of 2023, major projects within the company’s product development will be completed at the same time as the regulatory preparations for the new European regulatory framework MDR will be completed. Coala Life will also be able to optimize its resources in USA and Sweden, which also means lower costs. In total, the costs per SEK sold are estimated to decrease by 20% with full effect from Q2 2023. Against this background Coala Life calculates to reach positive cash flow and positive EBITDA in 2024 at the latest.
“Coala Life is on a very exciting growth journey in the rapidly growing market for Managed RPM in USA. We have gone from being a product company to being able to offer the clinics a comprehensive service within Managed RPM as a SaaS company. The company continues to deliver, with a high sequential…
